Targeted Antibodies in Dairy-Based Products

  • Lennart Hammarström
  • Carina Krüger Weiner
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 606)


Ethylene Glycol Tetraacetic Acid Ethylene Glycol Tetraacetic Acid Cryptosporidium Parvum Bovine Colostrum Ethylene Glycol Tetraacetic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aaltonen, A. S., Tenovuo, J., Lehtonen, O. P.,&Saksala, R. (1990). Maternal caries incidence and salivary close-contacts with children affect antibody levels to Streptococcus mutans in children. Oral Microbiology and Immunology, 5, 12–18.CrossRefGoogle Scholar
  2. Abrams, G. D., Allo, M., Rifkin, G. D., Fekety, R.,&Silva, J., Jr. (1980). Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis. Gut, 21, 493–499.CrossRefGoogle Scholar
  3. Acres, S. D., Isaacson, R. E., Babiuk, L. A.,&Kapitany, R. A. (1979). Immunization of calves against enterotoxigenic Colibacillosis by vaccinating dams with purified K99 antigen and whole cell bacterins. Infectious Immunology, 25, 121–126.Google Scholar
  4. Ando, K.,&Nakamura, T. (1991). A method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis and thus formulated medicines. European patent application no. 91310049.1.Google Scholar
  5. Bogstedt, A. K., Hammarström, L.,&Robertson, A. K. (1997). Survival of immunoglobulins from different species through the gastrointestinal tract in healthy adult volunteers: Implications for human therapy. Antimicrobial Agents of Chemotherapy, 41, 2320.Google Scholar
  6. Brinkworth, G. D.,&Buckley, J. D. (2003). Concentrated bovine colostrum protein supplementation reduces the incidence of self-reported symptoms of upper respiratory tract infection in adult males. European Journal of Nutrition, 42, 228–232.CrossRefGoogle Scholar
  7. Brock, J. H., Ortega, F.,&Pineiro, A. (1975). Bactericidal and haemolytic activity of complement in bovine colostrum and serum: Effect of proteolytic enzymes and ethylene glycol tetraacetic acid (EGTA). Annals of Immunology, 126C, 439–451.Google Scholar
  8. Brown, W. R., Rabbani, H., Butler, J. E.,&Hammarström, L. (1997). Characterization of the bovine gene. Immunology, 91, 1–6.CrossRefGoogle Scholar
  9. Brunser, O., Espinoza, J., Figueroa, G., Araya, M., Spencer, E., Hilpert, H., Link-Amster, H.,&Brüssow, H. (1992). Field trial of an infant formula containing anti-rotavirus and anti-Escherichia coli milk antibodies from hyperimmunized cows. Journal of Pediatric Gastroenterology and Nutrition, 15, 63–72.CrossRefGoogle Scholar
  10. Butler, J. E. (1983). Bovine immunoglobulins: An augmented review. Veterinary Immunology and Immunopathology, 4, 43–152.CrossRefGoogle Scholar
  11. Butler, J. E., Kiddy, C. A., Pierce, C. S.,&Rock, C. A. (1972a). Quantitative changes associated with calving in the levels of bovine immunoglobulins in selected body fluids. I. Changes in the levels of IgA, IgG1 and total protein. Canadian Journal of Comparative Medicine, 36, 234–242.Google Scholar
  12. Butler, J. E., Maxwell, C. F., Pierce, C. S., Hylton, M. B., Asofsky, R.,&Kiddy, C. A. (1972b). Studies on the relative synthesis and distribution of IgA and IgG1 in various tissues and body fluids of the cow. Journal of Immunology, 109, 38–46.Google Scholar
  13. Butler, J. E., Seawright, G. L., McGivern, P. L.,&Gilsdorf, M. (1986). Preliminary evidence for a diagnostic immunoglobulin G1 antibody response among culture-positive cows vaccinated with Brucella abortus strain 19 and challenge exposed with strain 2308. American Journal of Veterinary Research, 47, 1258–1264.Google Scholar
  14. Casswall, T. H., Sarker, S. A., Albert, M. J., Fuchs, G. J., Bergström, M., Björk, L.,&Hammarström, L. (1998). Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Alimentary Pharmacology and Therapy, 12, 563–568.CrossRefGoogle Scholar
  15. Casswall, T. H., Sarker, S. A., Faruque, S. M., Weintraub, A., Albert, M. J., Fuchs, N., Dahlström, A. K., Link, H., Brüssow, H.,&Hammarström, L. (2000). Treatment of enterotoxigenic and enteropathogenic Escherichia coli induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: A double-blind, placebo-controlled, clinical trial. Scandinavian Journal of Gastroenterology, 7, 711–718.CrossRefGoogle Scholar
  16. Casswall, T. H., Nilsson, H. O., Björck, L., Sjöstedt, S., Xu, L., Nord, C. K., Boren, T., Wadström, T.,&Hammarström, L. (2002). Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scandinavian Journal of Gastroenterology, 37, 1380–1385.CrossRefGoogle Scholar
  17. Cloud, J.,&Kelly, C. P. (2007). Update on Clostridium difficile associated disease. Current Opinion in Gastroenterology, 23, 4–9.CrossRefGoogle Scholar
  18. Crooks, C. V., Wall, C. R., Cross, M. L.,&Rutherford-Markwick, K. J. (2006). The effects of bovine colostrum supplementation on salivary IgA in distance runners. International Journal of Sport Nutrition and Exercise Metabolism, 16, 47–64.Google Scholar
  19. Davidson, G. P., Daniels, E., Nunan, H., Moore, A. G., Whyte, P. B. D., Franklin, K., McCloud, P. I.,&Moore, D. J. (1989). Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet, 2, 709–712.CrossRefGoogle Scholar
  20. Davidson, G. P., Tam, J.,&Kirubacaran, C. (1994). Passive protection against symptomatic hospital acquired rotavirus infection in India and Hong Kong. Journal of Pediatric Gastroenterology and Nutrition, 19, 351.CrossRefGoogle Scholar
  21. Ebina, T., Sato, A., Umezu, K., Ishida, N., Ohyama, S., Oizumi, A., Aikawa, K., Katagiri, S., Katsushima, N., Imai, A., Kitaoka, S., Suzuki, H.,&Konno, T. (1985). Prevention of rotavirus infection by oral administration of cow colostrum containing antihumanrotavirus antibody. Medical Microbiology and Immunology, 174, 177–185.CrossRefGoogle Scholar
  22. Fayer, R.,&Jenkins, M. C. (1992). Colostrum from cows immunized with Eimeria acervulina antigens reduces parasite development in vivo and in vitro. Poultry Science, 71, 1637–1645.Google Scholar
  23. Fayer, R., Andrews, C., Ungar, B. L.,&Blagburn, B. (1989). Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. Journal of Parasitology, 75, 393–397.CrossRefGoogle Scholar
  24. Fayer, R., Guidry, A.,&Blagburn, B. L. (1990). Immunotherapeutic efficacy of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice. Infectious Immunology, 58, 2962–2965.Google Scholar
  25. Filler, S. J., Gregory, R. L., Michalek, S. M., Katz, J.,&McGhee, J. R. (1991). Effect of immune bovine milk on Streptococcus mutans in human dental plaque. Archives in Oral Biology, 36, 41–47.CrossRefGoogle Scholar
  26. Freedman, D. J., Tacket, C. O., Delehanty, A., Maneval, D. R., Nataro, J.,&Crabb, J. H. (1998). Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. Journal of Infectious Diseases, 177, 662–667.Google Scholar
  27. Funatogawa, K., Ide, T., Kirikae, F., Saruta, K., Nakano, M.,&Kirikae, T. (2002). Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice. Medical Microbiology and Immunology, 46, 761–766.Google Scholar
  28. Graczyc, T. K., Cranfield M. R., Helmer, P., Fayer, R.,&Bostwick, E. F. (1998). Therapeutic efficacy of hyperimmune bovine colostrum treatment against clinical and subclinical Cryptosporidium serpentis infections in captive snakes. Veterinary Parasitology, 31, 123–132.CrossRefGoogle Scholar
  29. Greenberg, P. D.,&Cello, J. P. (1996). Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. Journal of AIDS, 13, 348–354.Google Scholar
  30. Harp, J. A., Woodmansee, D. B.,&Moon, H. W. (1989). Effects of colostral antibody on susceptibility of calves to Cryptosporidium parvum infection. American Journal of Veterinary Research, 50, 2117–2119.Google Scholar
  31. Hilpert, H., Brüssow, H., Mietens, C., Sidoti, J., Lerner, L.,&Werchau, H. (1987). Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. Journal of Infectious Diseases, 156, 158–166.Google Scholar
  32. Hoskins, D., Chrisp, C. E., Suckow, M. A.,&Fayer, R. (1991). Effect of hyperimmune bovine colostrum raised against Cryptosporidium parvum on infection of guinea pigs by Cryptosporidium wrairi. Journal of Protozoology, 38, 185S–186S.Google Scholar
  33. Howden, C. W. (1996). Clinical expressions of Helicobacter pylori infection. American Journal of Medicine, 100, 27S–32S.Google Scholar
  34. Huppertz, H. I., Rutkowski, S., Busch, D. H., Eisebit, R., Lissner, R.,&Karch, H. (1999). Bovine colostrum ameliorates diarrhea in infection with diarrheagenic Escherichia coli, Shiga toxin-producing E. coli, and E. coli expressing intimin and hemolysin. Journal of Pediatric Gastroenterology and Nutrition, 29, 452–456.CrossRefGoogle Scholar
  35. Isaacson, R. E., Dean, E. A., Morgan, R. L.,&Moon, H. W. (1980). Immunization of suckling pigs against enterotoxigenic Escherichia coli-induced diarrheal disease by vaccinating dams with purified K99 or 987P pili: Antibody production in response to vaccination. Infectious Immunology, 19, 824–826.Google Scholar
  36. Jansson, A., Nava, S., Brüssow, H., Mahanalabis, D.,&Hammarström, L. (1994). Titers of specific antibodies in immunized and non-immunized colostrum; implications for their use in the treatment of patients with gastrointestinal infections. InIndigenous Antimicrobial Agents of Milk—Recent Developments (pp. 221–228). Brussels: International Diary Federation Press.Google Scholar
  37. Jenkins, M. (2004). Present and future control of cryptosporidiosis in humans and animals. Expert Review of Vaccines, 3, 669–671.CrossRefGoogle Scholar
  38. Jenkins, M. C., O‘Brien, C., Trout, J., Guidry, A.,&Fayer, R. (1999). Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed mice. Vaccine, 17, 2453–2460.CrossRefGoogle Scholar
  39. Kacskovics, I.,&Butler, J. E. (1996). The heterogeneity of bovine IgG2. VIII. The complete cDNA sequence of bovine IgG2a (A2) and an IgG1. Molecular Immunology, 33, 189–195.CrossRefGoogle Scholar
  40. Kacskovics, I., Wu, Z., Simister, N. E.,&Hammarström, L. (2000). Cloning and characterization of the bovine MHC class I-like Fc receptor. Journal of Immunology, 164, 1889–1897.Google Scholar
  41. Kacskovics, I., Kis, Z., Mayer, B., West, A. P., Jr., Tiangco, N. E., Tilahun, M., Cervenak, L., Bjorkman, P. J., Goldsby, R. A., Szenci, O.,&Hammarström, L (2006). FcRn mediates elongated serum half-life of human IgG in cattle. International Immunology, 18, 525–536.CrossRefGoogle Scholar
  42. Kelly, C. P., Chetham, S., Keates, S., Bostwick, E. F., Roush, A. M., Castagliuolo, I., LaMont, J. T.,&Pothoulakis, C. (1997). Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrobial Agents of Chemotherapy, 41, 236–241.Google Scholar
  43. Kelly, P.,&Farthing, M. J. (1998). Bacterial infections of the gut (excluding enteric fever). Current Opinion in Infectious Diseases, 11, 577–582.Google Scholar
  44. Koga, T., Oho, T., Shimazaki, Y.,&Nakano, Y. (2002). Immunization against dental caries. Vaccine, 20, 2027–2044.CrossRefGoogle Scholar
  45. Korhonen, H., Syväoja, E.-L., Ahola-Luttila, H., Sivelä, S., Kopola, S, Husu, J.,&Kosunen, T. U. (1994). Helicobacter pylori-specific antibodies and bactericidal activity in serum, colostrum and milk of immunised and non immunised cows. Indigenous Antimicrobial Agents of Milk—Recent Developments. IDF Special Issue 9404, 4, 151–163.Google Scholar
  46. Korhonen, H., Syvaoja, E. L., Ahola-Luttila, H., Sivela, S., Kopola, S.,&Husu, J. (1995). Bactericidal effect of bovine normal and immune serum, colostrums and milk against Helicobacter pylori. Journal of Applied Bacteriology, 78, 655–662.Google Scholar
  47. Korhonen, H., Marnila, P.,&Gill, H. S. (2000). Bovine antibodies for health. British Journal of Nutrition, 84, S135–S146.Google Scholar
  48. Kuroiwa, Y., Kasinathan, P., Choi, Y. J., Naeem, R., Tomizuka, K., Sullivan, E. J., Knott, J. G., Duteau, A., Goldsby, R. A., Osborne, B. A., Ishida, I.,&Robl, J. M. (2002). Cloned transchromosomic calves producing human immunoglobulin. Nature Biotechnology, 20, 889–894.CrossRefGoogle Scholar
  49. Leresche, E., Paunier, L.,&Andrejevic, G. (1972). Stabilité dans le tractus digestif du nourrisson et tolerance clinique d’immunoglobulines bovines à teneur anticorps elevée contre les E. Coli pathogenes, administrées par voie orale. Comp Immun Microbiol Infect Dis, 1, 205–220.CrossRefGoogle Scholar
  50. Lissner, R., Schmidt, H.,&Karch, H. (1996). A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli O157:H7. Infection, 24, 378–383.CrossRefGoogle Scholar
  51. Lissner, R., Thürmann, P. A., Merz, G.,&Karch, H. (1997). Antibody reactivity and fecal recovery of bovine immunoglobulins following oral administration of a colostrum concentrate from cows (Lactobin) to healthy volunteers. International Journal of Clinical Pharmacological Therapy, 36, 239–245.Google Scholar
  52. Lodinová-Zàdnikovà, R., Korych, B.,&Bartakova, Z. (1987). Treatment of gastrointestinal infections in infants by oral administration of colostral antibodies. Die Nahrung, 31, 465–467.CrossRefGoogle Scholar
  53. Loimaranta, V., Tenovuo, J., Virtanen, S., Marnila, P., Syvaoja, E. L., Tupasela, T.,&Korhonen, H. (1997). Generation of bovine immune colostrum against Streptococcus mutans and Streptococcus sobrinus and its effect on glucose uptake and extracallular polysaccharide formation by mutans streptococci. Vaccine, 15, 1261–1268.CrossRefGoogle Scholar
  54. Loimaranta, V., Carlen, A., Olsson, J., Tenovuo, J., Syvaoja, E. L.,&Korhonen, H. (1998). Concentrated bovine colostral whey proteins from Streptococcus mutans/Strep. sobrinus immunized cows inhibit the adherence of Strep. mutans and promote the aggregation of mutans streptococci. Journal of Dairy Research, 65, 599–607.CrossRefGoogle Scholar
  55. Loimaranta, V., Nuutila, J., Marnila, P., Tenovuo, J., Korhonen, H.,&Lilius, E. M. (1999). Colostral proteins from cows immunised with Streptococcus mutans/S. sobrinus support the phagocytosis and killing of mutans streptococci by human leukocytes. Journal of Medical Microbiology, 48, 917–926.CrossRefGoogle Scholar
  56. Lyerly, D. M., Lockwood, D. E., Richardson, S. H.,&Wilkins, T. D. (1982). Biological activities of toxins A and B of Clostridium difficile. Infectious Immunology, 35, 1147–1150.Google Scholar
  57. Lyerly, D. M., Bostwick, E. F., Binion, S. B.,&Wilkins, T. D. (1991). Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infectious Immunology, 59, 2215–2218.Google Scholar
  58. Martin-Gomez, S., Alvarez-Sanchez, M. A.,&Rojo-Vazquez, F. A. (2005). Oral administration of hyperimmune anti-Cryptosporidium parvum ovine colostral whey confers a high level of protection against cryptosporidiosis in newborn NMRI mice. Journal of Parasitology, 91, 674–678.CrossRefGoogle Scholar
  59. Mayer, B., Doleschall, M., Bender, B., Bartyik, J., Bosze, Z., Frenyo, L. V.,&Kacskovics, I. (2005). Expression of the neonatal Fc receptor (FcRn) in the bovine mammary gland. Journal of Dairy Research, 72, 107–112.CrossRefGoogle Scholar
  60. McClead, R. E.,&Gregory, S. A. (1984). Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis. Infectious Immunology, 44, 474–478.Google Scholar
  61. McClead, R. E., Butler, T.,&Rabbani, G. H. (1988). Orally administered bovine colostral anti-cholera toxin antibodies: Results of two clinical trials. American Journal of Medicine, 85, 811–816.CrossRefGoogle Scholar
  62. Mietens, C., Keinhorst, H., Hilpert, H., Gerber, H., Amster, H.,&Pahud, J. J. (1979). Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins. European Journal of Pediatrics, 132, 239–252.CrossRefGoogle Scholar
  63. Mitchell, H. M. (1999). The epidemiology of Helicobacter pylori. Current Topics in Microbiology and Immunology, 24, 11–30.Google Scholar
  64. Mitra, A. K., Mahalanabis, D., Ashraf, H., Unicomb, L., Eeckels R.,&Tzipori, S. (1995). Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: A double-blind, controlled clinical trial. Acta Paediatrics, 84, 996–1001.Google Scholar
  65. Mousavi, M., Rabbani, H.,&Hammarström, L. (1997). Characterization of the bovine ɛ gene. Immunology, 92, 369–373.CrossRefGoogle Scholar
  66. Mousavi, M., Rabbani, H., Pilström, L.,&Hammarström, L. (1998). Characterization of the gene for the membrane and secretory form of the IgM heavy-chain constant region gene () of the cow (Bos taurus). Immunology, 93, 581–588.CrossRefGoogle Scholar
  67. Nomoto, K., Matsuoka, K., Hayakawa, K., Ohwaki, M., Kan, T.,&Yoshikai, Y. (1992). Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model. Medical Microbiology and Immunology, 181, 87–98.CrossRefGoogle Scholar
  68. Nord, J., Ma, P., DiJohn, D., Tzipori, S.,&Tacket, C. O. (1990). Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS, 4, 581–584.CrossRefGoogle Scholar
  69. Oona, M., Rägo, T., Maaroos, H., Mickelsaar, M., Loivukene, K., Salminen, S.,&Korhonen, K. (1997). Helicobacter pylori children with abdominal complaints: Has immune bovine colostrum some influence on gastritis? Alpe Adr Microbiol Journal, 6, 49–57.Google Scholar
  70. Opekun, A. R., El-Zaimaity, H. M., Osato, M. S., Gilger, M. A., Malaty, H. M., Terry, M., Headon, D. R.,&Graham, D. Y. (1999). Novel therapies for Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics, 13, 35–41.CrossRefGoogle Scholar
  71. Osame, S., Ichijo, S., Ohta, C., Watanabe, T., Benkele, W.,&Goto, H. (1991). Efficacy of colostral immunoglobulins for therapeutic and preventive treatments of calf diarrhea. Journal of Veterinary Medical Science, 53, 87–91.Google Scholar
  72. Perryman, L. E., Riggs, M. W., Mason, P. H.,&Fayer, R. (1990). Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum. Infectious Immunology, 58, 257–259.Google Scholar
  73. Playford, R. J., Floyd, D. N., Macdonald, C. E., Calnan, D. P., Adenekan, R. O., Johnson, W., Goodlad, R. A.,&Marchbank., T. (1999). Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut, 44, 653–658.Google Scholar
  74. Playford, R. J., MacDonald, C. E., Calnan, D. P., Floyd, D. N., Podas, T., Johnson, W., Wicks, A. C., Bashir, O.,&Marchbank, T. (2001). Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clinical Science, 100, 627–633.CrossRefGoogle Scholar
  75. Plettenberg, A., Stoehr, A., Stellbrink, H. J., Albrecht, H.,&Meigel, W. (1993). A preparation from bovine colostrum in the treatment of HIV positive patients with chronic diarrhea. Clinical Investigations, 71, 42–45.Google Scholar
  76. Rabbani, H., Brown, W. R., Butler, J. E.,&Hammarström, L. (1997). Polymorphism of the IGHG3 gene in cattle. Immunogenetics, 46, 326–331.CrossRefGoogle Scholar
  77. Riggs, M. W. (1997). Immunology: Host response and development of passive immunotherapy and vaccines In R. Fayer (Ed.), Cryptosporidium and Cryptosporidiosis (pp. 129–162). Boca Raton, FL: CRC Press.Google Scholar
  78. Rokka, S., Korhonen, B. H., Nousiainen, J.,&Marnila, P. (2001). Colostral whey concentrate supplement increases complement activity in the sera of neonatal calves. Journal of Dairy Research, 68, 357–367.CrossRefGoogle Scholar
  79. Roos, N., Mahé, S., Benamouzig, R., Sick, H., Rautureau, J.,&Tomé, D. (1995). 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. Journal of Nutrition, 125, 1238–1244.Google Scholar
  80. Rump, J. A., Arndt, R., Arnold, A., Bendick, C., Dichtelmüller, H., Franke, M., Helm, B. B., Jäger, H., Kampmann, B., Kolb, P., Kreuz, W., Lissner, R., Meigel, W., Ostendorf, P., Peter, H. H., Plettenberg, A., Schedel, I., Stellbrink, H. W.,&Stephan, W. (1992). Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clinical Investigations, 70, 588–594.Google Scholar
  81. Sarker, S. A., Casswall, T. H., Mahalanabis, D., Alam, N. H., Albert, M. J., Brüssow, H., Fuchs, G. J.,&Hammarström, L. (1998). Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatric Infectious Disease Journal, 17, 1149–1154.CrossRefGoogle Scholar
  82. Saxon, A.,&Weinstein, W. (1987). Oral administration of bovine colostrum anti-Cryptosporidia antibody fails to alter the course of human Cryptosporidios. Journal of Parasitology, 73, 413–415.CrossRefGoogle Scholar
  83. Schaller, J. P., Saif, L. J., Cordle, C. T., Candler, E., Jr., Winship, T. R.,&Smith, K. L. (1992). Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. Journal of Infectious Diseases, 165, 623–630.Google Scholar
  84. Shimazaki, Y., Mitoma, M., Oho, T., Nakano, Y., Yamashita, Y., Okano, K., Nakano, Y., Fukuyama, M., Fujihara, N., Nada, Y.,&Koga, T. (2001). Passive immunization with milk produced from an immunized cow prevents oral recolonization by Streptococcus mutans. Clinical and Diagnostic Lab Immunology, 8, 1136–1139.CrossRefGoogle Scholar
  85. Snodgrass, D. R., Nagy, L. K., Sherwood, D.,&Campbell, I. (1982). Passive immunity in calf diarrhea: Vaccination with K99 antigen of enterotoxigenic Escherichia coli and rotavirus. Infectious Immunology, 37, 586–591.Google Scholar
  86. Stephan, W., Dichtelmüller, H.,&Lissner, R. (1990). Antibodies from colostrum in oral immunotherapy. Journal of Clinical and Chemical Biochemistry, 28, 19–23.Google Scholar
  87. Tacket, C. O., Losonsky, G., Link, H., Hoang, Y., Guesry, P., Hilpert, H.,&Levine, M. M. (1988). Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. New England Journal of Medicine, 318, 1240–1243.CrossRefGoogle Scholar
  88. Tacket, C. O., Binion, S., Bostwick, E., Losonsky, G., Roy, M. J.,&Edelman, R. (1992). Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. American Journal of Tropical Medicine and Hygiene, 47, 276–283.Google Scholar
  89. Tarpila, S., Korhonen, H.,&Salminen, S. (1995). Immune colostrum in the treatment of Helicobacter pylori gastritis. In Abstract Book of the 24th International Dairy Congress. Melbourne, Australia (pp. 18–22)..Google Scholar
  90. Tawfeek, H. I., Najim, N. H.,&Al-Mashikhi, S. (2003). Efficacy of an infant formula containing anti-Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: A field trial. International Journal of Infectious Diseases, 7, 120–128.CrossRefGoogle Scholar
  91. Tollemar, J., Gross, N., Dolgiras, N., Jarstrand, C., Ringdén, O.,&Hammarström, L. (1999). Passive immunity against Candida in bone-marrow transplanted patients: Reduction of salivary yeast counts by oral administration of bovine anti-Candida antibodies. Bone Marrow Transplant, 23, 283–290.CrossRefGoogle Scholar
  92. Tsubokura, K., Berndtson, A., Bogstedt, A., Kaijser, B., Kim, M., Ozeki, M.,&Hammarstrom, L. (1997). Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni-infected chickens. Clinical Experiments in Immunology, 108, 451–455.CrossRefGoogle Scholar
  93. Turner, R. B.,&Kelsey, D. K. (1993). Passive immunization for prevention of rotavirus illness in healthy infants. Pediatric Infectious Disease Journal, 12, 718–722.Google Scholar
  94. Tzipori, S., Robertson, D.,&Chapman, C. (1986). Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. British Medical Journal, 293, 1276–1277.Google Scholar
  95. Tzipori, S., Robertson, D., Cooper, D.,&White, L. (1987). Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet, 2, 344–345.CrossRefGoogle Scholar
  96. Ungar, B. L., Ward, D. J., Fayer, R.,&Quinn, C. A. (1990). Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology, 98, 486–489.Google Scholar
  97. van Dissel, J. T., de Groot, N., Hensgens, C. M., Numan, S., Kuijper, E. J., Veldkamp, P.,&van't Wout, J. (2005). Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: Preclinical and preliminary clinical data. Journal of Medical Microbiology, 54, 197–205.CrossRefGoogle Scholar
  98. van Zaane, D., Ijzerman, J.,&De Leeuw, P. W. (1986). Intestinal antibody response after vaccination and infection with rotavirus of calves fed colostrum with or without rotavirus antibody. Veterinary Immunology and Immunopathology, 11, 45–63.CrossRefGoogle Scholar
  99. Ward, S. J., Douce, G., Dougan, G.,&Wren, B. W. (1999). Local and systemic neutralizing antibody responses, induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile. Infectious Immunology, 67, 5124–5132.Google Scholar
  100. Warny, M., Fatimi, A., Bostwick, E. F., Lebel, F., LaMont, J. T., Pothoulakis, C.,&Kelly C. P. (1999). Bovine immunoglobulin concentrate-Clostridium difficile retains C. difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut, 44, 212–217.CrossRefGoogle Scholar
  101. Weiner, C., Pan, Q., Hurtig, M., Borén, T., Bostwick, E.,&Hammarström, L. (1999). Passive immunity against human pathogens using bovine antibodies. Clinical Experiments in Immunology, 116, 193–205.CrossRefGoogle Scholar
  102. Xu, L. B., Chen, L., Gao, W.,&Du, K. H. (2005). Bovine immune colostrum against 17 strains of diarrhea bacteria and in vitro and in vivo effects of its specific IgG. Vaccine, 24, 2131–2140.CrossRefGoogle Scholar
  103. Ylitalo, S., Uhari, M., Rasi, S., Pudas, J.,&Leppaluoto, J. (1998). Rotaviral antibodies in the treatment of rotaviral gastroenteritis. Acta Paediatrics, 87, 264–267.CrossRefGoogle Scholar
  104. Yolken, R., Losonsky, G. A., Vonderfecht, S., Leister, F.,&Wee, S.-B. (1988). Antibody to human rotavirus in cow's milk. New England Journal of Medicine, 312, 605–610.CrossRefGoogle Scholar
  105. Zhao, Y., Kacskovics, I., Pan, Q., Liberles, D. A., Geli, J., Davis, S. K., Rabbani, H.,&Hammarström, L. (2002). Artiodactyl IgD: The missing link. Journal of Immunology, 169, 4408–4416.Google Scholar
  106. Zhao, Y., Kacskovics, I., Rabbani, H.,&Hammarström, L. (2003). Physical mapping of the bovine immunoglobulin heavy chain constant region gene locus. Journal of Biological Chemistry, 278, 35024–35032.CrossRefGoogle Scholar
  107. Zhao, Y., Jackson, S. M.,&Aitken, R. (2006). The bovine antibody repertoire. Developmental and Comparative Immunology, 30, 175–186.CrossRefGoogle Scholar
  108. Zinkernagel, R. M., Hilpert, H.,&Gerber, H. (1972). The digestion of colostral bovine immunoglobulins in infants. Experientia, 28, 741.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Lennart Hammarström
    • 1
  • Carina Krüger Weiner
  1. 1.Division of Clinical Immunology, Department of Laboratory MedicineKarolinska University Hospital HuddingeSweden

Personalised recommendations